578
Participants
Start Date
August 31, 2017
Primary Completion Date
December 31, 2018
Study Completion Date
December 31, 2018
Risk reduction counseling
Subjects will receive comprehensive prevention package including HIV and safe sex counseling, provision of condoms and water-based lubricant, and STI screening and referral for treatment.
Social harm interview
Information regarding social harms (loss of privacy, stigmatization, interference with gainful employment, and coercion) will be solicited during bi-monthly study visits after enrollment in the study and will be recorded. Subjects who report social harms will be referred to speak with a social worker and/or a study counselor.
Computer-Assisted Self Interviewing technique
Demographic, behavioral, and psychosocial factors associated with HIV acquisition will be assessed by CASI.
GSK Investigational Site, Beijing
GSK Investigational Site, Beijing
GSK Investigational Site, Shenyang
GSK Investigational Site, Shanghai
GSK Investigational Site, Hangzhou
GSK Investigational Site, Changsha
GSK Investigational Site, Guangzhou
GSK Investigational Site, Shenzhen
GSK Investigational Site, Chengdu
Lead Sponsor
ViiV Healthcare
INDUSTRY